Home
About
Publications Trends
Recent Publications
Expert Search
Archive
parathyroid hormone (pth)
Which Cancers Are Associated with Elevated PTH or PTHrP Levels?
Several types of cancers are known to be associated with elevated levels of PTH or PTHrP, including:
Breast cancer
Lung cancer
Renal cell carcinoma
Multiple myeloma
These cancers can either secrete PTHrP or cause bone metastases, leading to increased bone resorption and calcium release.
Frequently asked queries:
What is Parathyroid Hormone (PTH)?
How is PTH Related to Cancer?
Which Cancers Are Associated with Elevated PTH or PTHrP Levels?
What are the Symptoms of Hypercalcemia in Cancer Patients?
How is Hypercalcemia Diagnosed and Managed in Cancer Patients?
How are Systematic Reviews Conducted?
What Are the Alternatives for Hypertension Management in Cancer Patients?
Should One Avoid Certain Fruits and Vegetables?
What is the Prognosis for Patients with Acute Leukemias?
What Role Do Healthcare Professionals Play in Cancer Education?
How Can Emotional Support be Provided?
How is Sensitive Data Protected?
What are Phase II Trials?
Why is Selection Bias a Concern in Cancer Studies?
What Laws Protect Employees with Cancer?
What is the Role of a Cancer Nurse?
What role do biomarkers play in cancer diagnosis and treatment?
How can appointment reminders be tailored to meet the needs of individual patients?
What is the TRIPS Agreement?
How Does TP53 Testing Affect Treatment?
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Lung Cancer
Nanotechnology
Non-Hodgkin’s Lymphoma
Radiation-Induced Malignancies
Follow Us
Facebook
Linkedin
Youtube
Instagram
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
Carcinogenesis
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
Chronic inflammation
CIAbimatoprost
Co-morbidity
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
Diagnosis challenges
diffuse large B-cell lymphoma
DNA damage
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Fibrosis
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunosuppression
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
intensity-modulated radiation therapy
Keratinocyte
Lipid-based nanoparticles
liver cancer
long-term cancer risks
Lung cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Multidisciplinary care
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
proton therapy
Radiation-induced malignancies
radiotherapy
refractory lymphoma
relapsed lymphoma
Risk factors
secondary cancer prevention
secondary cancers
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
Tuberculosis
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe